Details of the Drug

General Information of Drug (ID: DMMCEV0)

• Drug Name: GI-5005

Indication

Disease Entry	ICD 11	Status	REF
Chronic HCV-1 infection	1E51.1	Phase 2	[1]
Hepatitis C virus infection	1E51.1	Phase 2	[1]

• Cross-matching ID: TTD ID: D0J6NV

References

• [1] ClinicalTrials.gov (NCT00606086) Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection. U.S. National Institutes of Health.